ArticleFrontiers in public health2022

The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study.

Khalid Al Sulaiman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.